Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap
Saved in:
Main Authors: | Lucia Gozzo (Author), Laura Longo (Author), Daniela Cristina Vitale (Author), Filippo Drago (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience
by: Lucia Gozzo, et al.
Published: (2020) -
The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review
by: Lucia Gozzo, et al.
Published: (2020) -
The therapeutic value of treatment for multiple sclerosis: analysis of health technology assessments of three European countries
by: Lucia Gozzo, et al.
Published: (2023) -
Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies
by: Claudio Bucolo, et al.
Published: (2018) -
Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries
by: Lucia Gozzo, et al.
Published: (2021)